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ABSTRACT: Pediocin PA-1 is a broad-spectrum lactic acid bacteria bacteriocin that shows a particularly strong
activity against Listeria monocytogenes, a foodborne pathogen of special concern among the food industries. This
antimicrobial peptide is the most extensively studied class IIa (or pediocin family) bacteriocin, and it has been
sufficiently well characterized to be used as a food biopreservative. This review focuses on the progress that have
been made in the elucidation of its structure, mode of action, and biosynthesis, and includes an overview of its
applications in food systems. The aspects that need further research are also addressed. In the future, protein
engineering, genetic engineering and/or chemical synthesis may lead to the development of new antimicrobial
peptides with improved properties, based on some features of the pediocin PA-1 molecule.
KEY WORDS: pediocin PA-1, bacteriocins, lactic acid bacteria, food preservatives, antimicrobials, food safety,
Listeria monocytogenes.
I. INTRODUCTION
Bacteriocins of lactic acid bacteria (LAB) are
attractive to the food industry because they may
be used as natural biopreservatives and contribute
to the improvement of the microbiological quality
of foods.1 Also, the use of these ribosomally syn-
thesized antimicrobial peptides may allow a sig-
nificant reduction in the level of chemical addi-
tives and/or in the intensity of the physical
treatments currently employed during food pro-
cessing. Therefore, they could also help to pro-
vide healthier foods.2
Since the late 1920s, when the first reports on
the antimicrobial activity of a lactococcal bacterio-
cin (later called nisin) were made, a large number
of LAB bacteriocins have been identified, particu-
larly in the last few years. On a scientific basis,
LAB bacteriocins can be divided into three main
classes:3,4 class I (lantibiotics), class II (small heat-
stable nonlantibiotics), and class III (large heat-
labile bacteriocins). Class IIa, one of the subgroups
in which class II bacteriocins may be divided, is
also termed the “pediocin family” after the first and
most extensively studied representant of this class,
pediocin PA-1.4 Members of this subgroup
(“pediocin-like” bacteriocins) show very strong
antilisterial activity and have 40 to 60% sequence
similarity (Table 1). The N-terminal region is par-
ticularly well conserved and contains a conserved
“pediocin box” motif (YGNGVXCXK).5
Nisin is currently the only bacteriocin licenced
as a food additive in over 45 countries.6 However,
several studies have shown that there are other
LAB bacteriocins with potential for use as food
preservatives, particularly class IIa bacteriocins
due to their antilisterial activity.7 In fact, the
biopreservative potential of pediocin PA-1 has
already been commercially exploited. The pediocin
PA-1-containing fermentate AltaTM 2341 is a com-
mercial food ingredient reported to extend the
































inhibit the growth of Listeria monocytogenes in
ready-to-eat meat products.
In the past, several pediocin PA-1-producing
LAB strains were independently isolated in dif-
ferent labs.8-19 However, in many cases the bacte-
riocin produced received different names (e.g.,
pediocins PA-1, AcH, JD, Bac and 347,
mesentericin 5) before identification and realiza-
tion that all were the same molecule. As it is
desirable to conform to a uniform nomenclature,1
the more widespread name, pediocin PA-1, has
been adopted for this review.
Despite the fact that pediocin PA-1-produc-
ing LAB have been inadvertly or empirically used
as starter cultures for many years, most of the
current knowledge on pediocin PA-1 has been
generated since 1992. In that year, the determina-
tion of the pediocin PA-1 amino acid sequence,20-21
the application of improved protocols for its pu-
rification,21 and the identification of the pediocin
PA-1 operon,22-23 greatly facilitated research on
this subject. In addition, the continuous develop-
ment of new and improved biotechnological tools
have favored the increasing number of studies
dedicated to this bacteriocin. The purpose of this
article is to review the now enormous literature
on an antimicrobial peptide with such industrial
potential. Advances in the understanding of its
structure, mode of action, and biosynthesis will
be highlighted. Following that, we discuss the
development of methods that allow its specific
detection and quantification. The results of the
studies involving application of pediocin PA-1 in
food substrates will also be presented. Finally, the
last part of this review exposes the main conclu-




The primary structure of pediocin PA-1 has
been determined by Edman degradation of the
purified peptide and by sequence analysis of the
structural gene.20-23 Pediocin PA-1 is a 44 amino
acid peptide with no postranslational modifica-
tions.20-21 The primary structure seems enough to
induce toxicity on sensitive cells as synthetic
pediocin is biologically active and has a specific
activity comparable to that of the natural form.24
Other remarkable characteristics of the molecule
are the absence of phenylalanine, leucine,
glutamine, or arginine residues and the presence
of four lysine and three histidine residues and
only one aspartate. Titration of free cysteine resi-
dues with Ellman’s reagent, tryptic cleavage pat-
terns, mass spectrometry data, and pediocin re-
duction in the presence of dithiothreitol (DTT)
have provided evidence for the four cysteine resi-
dues forming two disulfide bonds (C9-C14 and
C24-C44),20,24-26 which are also spontaneously
formed in synthetic pediocin PA-1.24 As a reflec-
tion of its amino acid composition and sequence,
pediocin PA-1 is a cationic peptide with a basic
pI. Values ranging from +7 to +3 have been re-
ported for the net charge at pH 6,1,27,28 and from
8.6 to 10 for the pI.1,20,21,29 A comparison of the
primary structures of the pediocin-like bacterio-
cins suggests that their polypeptide chains can be
divided into two functional modules, a conserved
hydrophilic N-terminal β-sheet and a more di-
verse hydrophobic or amphiphilic C-terminal
α-helical domain24,30 (Table 1).
Initially, the secondary structural organiza-
tion of the peptide was predicted by Henderson et
al.20 following primary sequence analysis by Chou-
Fasman and Kyte-Coolite protocols. It is pro-
posed that the structure would consist of random
coils and β-turns with a propensity of residues A21
through I25 for a β-sheet and a primarily hydro-
philic profile except for the predicted β-sheet area.
In addition, the fragment T22 to A34 that contains
the single tryptophan and methionine residues
would define a hydrophobic region in close spa-
tial proximity with the C-terminus due to the
disulfide bond C24-C44.
More recently, Chen et al.27 predicted the
pediocin PA-1 secondary structure on the basis of
single and multiple sequence alignments and built
a model for its 19 N-terminal amino acids. The
model consisted of two β-strands connected by a
tight 4-residues β-hairpin. The N-terminal β-turn
would include the consensus sequence (YGNGV)
of class IIa bacteriocins, and the tip of the
β-hairpin would contain two positively charged
residues (K11 and H12). The C24-C44 disulfide bond
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would bring together H42, K43, and possibly K20.
NMR data had previously shown an ordered
β-structure in the vicinity of the two cysteine
residues (C9 and C14) of leucocin A, another class
IIa bacteriocin.31 Figure 1 shows a model of the
pediocin PA-1 structure.
B. Molecular Weight
The theoretical molecular weight of pediocin
PA-1, calculated from the amino acid sequence,
could be 4628 or 4624 Da, in the absence or
presence of two disulfide bonds, respectively.20,24
Experimental determination of the molecular
weights of natural and synthetic pediocin by
electrospray mass spectrometry revealed that the
cysteine residues are oxidized and joined by two
disulfide bonds.16,17,24 Previously, a molecular
weight of approximately 16,500 had been esti-
mated by gel filtration of a partially purified
sample. This value was nearly an exact multiple
of the actual molecular weight, suggesting the
presence of a stable tetramer.8
C. Solubility and Stability
The fact that many studies on pediocin PA-1
solubility and stability have been performed with
partially purified samples makes it difficult to
directly compare results obtained by different
authors.
Pediocin PA-1 is stable in dilute aqueous
solutions, although the molecules can form active
aggregates and tend to do so more readily as the
pediocin concentration increases and at refrigera-
tion temperatures.10 Aggregation seems to involve
components of the growth medium rather than
being an autocatalytic process because in contrast
to pediocin PA-1 in supernatants or to partially
purified samples, the homogeneous peptide does
not aggregate even at high concentrations.20
Samples containing pediocin PA-1 retained
total or partial activity after exposure for 24 h to
pH values ranging from 2 to 10 at room tempera-
ture, although the highest stability was achieved
between pH 4 and 6.8,10 Evaluation of the residual
activity after storage at 15°C of a culture extract
from Lb. plantarum WHE 92 showed that pediocin
PA-1 was perfectly stable after 21 days when the
pH of the extract was mantained at 4, 5, or 6, but
half of the activity dissapeared at pH 7.17 Al-
though antimicrobial activity was unaffected by
heating at 80°C for 60 min and at 100°C for 10
min, the effect of a treatment at 121°C for 15 min
is controversial as values of residual activity of
6%8 and 60%10 have been reported. Freezing
(–25°C) or refrigeration (0 to 8°C) storage did not
reduce the activity of pediocin samples after 6
months and 12 weeks, respectively.32 In contrast,
activity was stable at room temperature (22 to
25°C) for 6 weeks, but then it progressively de-
creased and over 50% was lost in 12 weeks.32
Recently, it has been shown that purified pediocin
PA-1 stored at 4 and 25°C is stable at pH 5 but not
at pH 7, while it remains stable after storage at
–20°C at both pH values.33
Pediocin PA-1 activity is unaffected by treat-
ment with phospholipase C, catalase, lysozyme,
Dnases, Rnases, or lipases but is lost after incuba-
tion with proteolytic enzymes such as trypsin,
papain, ficin, α-chimotrypsin, protease IV, pro-
tease XIV, protease XXIV, and proteinase K.8,10,34
Pediocin activity rapidly decreased when moni-
tored in a culture of Lb. plantarum WHE 92, most
probably because of hydrolysis by proteolytic
enzymes produced at the end of the exponential
growth phase.17 As a result, the percentage of
residual activity ranged from 1 to 6% after 21
days of incubation at 15°C. The absence of con-
taminating proteases may also explain why syn-
thetic pediocin is more stable than the molecule
isolated from the natural source.24
After storage in 30% acetonitrile-0.1%
trifluoroacetic acid (TFA) for 1 week or more at
–15°C, pediocin molecules became oxidized,
showing a molecular weight increase of 16 or
multiples of 16.16 Similarly, after storage in 30%
2-propanol-0,1% TFA for 8 months at 4°C, about
50% of natural and synthetic pediocin had been
transformed to a more hydrophilic and less active
form (pediocin PA-1-ox).24 The pediocin PA-1-ox
molecular weight had increased by 16 relative to
that of pediocin PA-1 and had suffered a 100- to
200-fold reduction in its specific activity. The
oxidation of the sulfur atom of the methionine


























































































































































































































to sulfoxide in the pediocin PA-1-ox molecule
may explain the increase in molecular weight and
hydrophilicity without charge alteration.24 Re-
cently, site-directed mutagenesis studies were
performed to obtain methionine-free pediocin PA-1
variants.33 Although mutating Met31 to Asp nulli-
fied bacteriocin activity, other methionine-free
pediocin PA-1 variants (Met31 to a hydrophobic
amino acid, such as Ala, Leu, or Ile) displayed
higher storage stability without a concomitant large
loss of activity.
D. Purification
Because pediocin PA-1 is a secreted peptide,
most of the purification protocols start with the
concentration of cell-free supernatants obtained
from the producing strains prior to the application
of chromatography-based techniques.
Initially, Gonzalez and Kunka8 partially puri-
fied pediocin PA-1 by ammonium sulfate precipi-
tation and two successive ion-exchange chromato-
graphic steps of the reconstituted dialyzed
precipitate. However, no data were provided on
the evolution of the specific activity through the
purification process. After a similar precipitation
step, Bhunia et al.10 employed gel filtration and
anion-exchange chromatographies, both integrated
in an FPLC system. The activities of the final
fractions were up to 98 times higher than those of
the respective supernatants.
The ability of this bacteriocin to adsorb to
the cell envelope of the producing cells was the
basis of the purification method developed by
Yang et al.35 These authors adjusted the pH of
a fully grown culture to pH 6, a value coinci-
dent with the highest adsorption efficiency.
Then, cells were collected by centrifugation
and the pH of the cell suspension was read-
justed to 2 for bacteriocin release. The suspen-
sion was applied to a reverse-phase column
coupled to an HPLC system and 106% of the
initial activity was recovered Daba et al.16 fol-
lowed a similar approach and the elution pro-
file revealed two peaks with antimicrobial ac-
tivity. The large HPLC peak corresponded to
pediocin PA-1, while the minor peak contained
oxidized forms of the bacteriocin.
In 1992, Henderson et al.20 purified pediocin
PA-1 to homogeneity by sucessive gel filtration
of the supernatant, ion-exchange chromatogra-
phy, dialysis and, finally, reverse-phase chroma-
tography coupled to HPLC. Although the yield
was only 0.6%, the final sample was pure enough
to allow pediocin PA-1 amino acid sequencing.
Simultaneously, Nieto-Lozano et al.21 also puri-
fied this bacteriocin to homogeneity and sequenced
it. Their purification procedure, with a signifi-
cantly higher activity yield (600%), included
ammonium sulfate precipitation, followed by three
chromatographic steps (cation-exchange, hydro-
phobic interaction, and reverse-phase chromatog-
raphy, respectively).36-37 This basic protocol, with
slight modifications, has been widely and suc-
cessfully applied for the purification of a large
number of LAB bacteriocins. Usually, the final
reverse-phase chromatography step is repeated
two or three times to ensure maximum purity. In
addition, the use of large volumes of washing
buffer for the washing steps during ion-exchange
and hydrophobic interaction chromatographies
may contribute considerably to purity,26 while a
gel filtration step prior to the cation-exchange
chromatography may increase the purification
yield.38-41 Recently,42 another chromatography-
based method consisting in three steps (ion-ex-
change, solid phase extraction, and reverse phase
HPLC) has been applied successfully to obtain
highly pure class IIa bacteriocins, including
pediocin PA-1.
Pediocin PA-1 has also been purified by a pro-
tocol, including ethanol precipitation, preparative
isoelectric focusing, and ultrafiltration.29 About 32%
of the pediocin contained in the culture supernatants
was precipitated with cold ethanol. Almost no activ-
ity (3%) was lost during isoelectric focusing and all
activity remained after ultrafiltration. The major
advantage of this method was the omission of chro-
matography steps, avoiding losses due to bacterio-
cin sticking to the matrix of the columns.
Ideally, the methods used for bacteriocin purifi-
cation should have high final yields, low costs, and
a high reproducibility. The purification protocols
cited above involve several steps that make the pro-
cess inefficient, laborious, and/or expensive, espe-
cially if scaling-up for industrial purposes is desired.
Construction of immunoaffinity columns using
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pediocin PA-1-specific-antibodies may constitute an
alternative approach for the simple (even single-
step) purification of pediocin PA-1. Nisin mono-
clonal antibodies43 were used successfully for the
one-step purification of this lantibiotic in 5 ml
immunoaffinity columns, although scaling-up has
not been evaluated yet.44 In this context, the recent
generation of polyclonal antibodies that specifically
recognize pediocin PA-1 is a promising step.40,41
III. BIOLOGICAL PROPERTIES
A. Antimicrobial Spectrum
Pediocin PA-1 displays antimicrobial activity
against a wide spectrum of Gram-positive bacteria,
many of them responsible for food spoilage or
foodborne diseases. The activity of pediocin PA-1
against Listeria monocytogenes, a microorganism
with the highest mortality rate among foodborne
bacteria in Western Europe and North America, is
particularly relevant. Therefore, many studies on
the biological activity of this peptide have been
focused on its effects on L. monocytogenes cells.45
Interestingly, pediocin PA-1 is not active against
bacteria used frequently in starter cultures, such as
lactococci. Pediocin PA-1 has similar MIC values
at 20, 30, and 37°C, and its C-terminal disulfide
bridge is a major determinant of the antimicrobial
spectrum.46 The structure and composition of the
outer membrane of Gram-negative bacteria do not
allow pediocin access to its target, the cytoplasmic
membrane. However, many Gram-negative organ-
isms (such as Salmonella typhimurium, Escheri-
chia coli, Serratia liquefaciens, and Pseudomonas
fluorescens strains) are pediocin PA-1-sensitive
after inflicting sublethal injuries (like freezing,
gentle heating, exposure to lactic acid or EDTA, or
hydrostatic-pressure pasteurization) to the outer
membranes, rendering their cytoplasmic mem-
branes accessible to pediocin molecules.47-51
B. Quantification of the Antimicrobial
Activity
Currently, the agar diffusion test is one of the
most widely used methods to detect bacteriocin
activity. Several arbitrary units have been defined
to quantify the antimicrobial activity of pediocin
PA-1 on solid media. Bhunia et al.10 employed
“antimicrobial activity units” (AAU) calculated
as the reciprocal of the antimicrobial titre multi-
plied by the dilution factor and divided by the
protein concentration (in mg) determined by the
Lowry method. The titre was defined as the recip-
rocal of the highest dilution producing a clear
zone of inhibition of 2 mm or larger on an
Lb. plantarum WSO-39 lawn.52 Later, Gonzalez
and Kunka8 defined one “arbitrary unit” (AU) of
bacteriocin as 5 µl of the highest dilution of cul-
ture supernatant yielding a definite zone of growth
inhibition on a lawn of the indicator P. pentosaceus
FBB63. This unit was also adopted by other au-
thors.20,53-55
Turbidometric methods, such as the microtitre
plate assay,36,56 are also used to detect and quan-
tify pediocin activity.19,21,38-40 In this system, one
bacteriocin unit (BU) is defined as the reciprocal
of the sample dilution, which inhibits growth of
the indicator organism by 50%, as indicated by
spectrophotometric measures. This method is very
useful to evaluate the activity of the different
fractions obtained during pediocin PA-1 purifica-
tion.
In contrast to nisin, there is no international
unit refering to the activity of an international
reference sample of pediocin PA-1. It is impos-
sible to compare arbitrary antimicrobial activity
values in cultures, culture supernatants, or (par-
tially) purified pediocin PA-1 obtained by differ-
ent authors, even if they use the same assay,
because the MICs values for vegetative cells and
spores may significantly differ depending on the
producing or indicator strains, the sample prepa-
ration method, and the bacteriocin assay condi-
tions.57 In addition, the major drawback of the
assays cited above is their unspecificity. In this
context, the recent development of pediocin PA-1
specific polyclonal antibodies enables the spe-
cific quantification of the pediocin present in a
sample by using a wide array of immunoassay
formats.40,41
Detecting a specific bacteriocin by searching
for a compound with a determined molecular mass
may be a practical approach to confirm the pres-
ence of pediocin PA-1 in cultures or foodstuffs.
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Matrix-assisted laser desorption/ionization time-
of-flight mass spectrometry (MALDI-TOF MS)
has been used recently for rapid detection of
pediocin PA-1, nisin, brochocins A and B and
enterocins A and B, from culture supernatants.58
Compared with other spectrometric techniques,
MALDI-TOF MS offers some advantages for the
routine analysis of bacteriocins, including ease of
use, picomolar to femtomolar sensitivity, high
mass range, ability to give extremely accurate
mass values, and relative tolerance to sample con-
taminants.58
C. Resistance to Pediocin PA-1
The emergence of organisms highly tolerant or
naturally resistant to class II bacteriocins has be-
come quite common and is a potential obstacle to
their application as food biopreservatives.59 Al-
though the ecology and mechanisms of resistance
to many traditional antibiotics have been studied
profusely, little is known on these aspects in the
bacteriocin field.60,61 However, investigations on
this subject will rapidly increase in the near future
because of the industrial interest in the application
of bacteriocins and/or bacteriocinogenic LAB to
improve the microbiological quality of foods.
Sensitivity to pediocin PA-1 differs greatly
between species and strains evaluated,18,59,62
atlhough pediocin PA-1-resistant or -tolerant
strains seem to occur more frequently than strains
displaying resistance or tolerance to nisin.59
Growth of surviving cells of L. monocytogenes
strains in pediocin PA-1-treated foods during re-
frigeration storage (4 and 10°C) has been re-
ported,53,62 and the population levels of some strains
reached very high numbers in a short time,62 even
in the presence of residual pediocin. As reduction
in Listeria counts was greater with higher levels
of pediocin, it has been suggested that the level of
pediocin (or other bacteriocins) should be ad-
justed to obtain maximum viability loss of the
most resistant strain when used as a food preser-
vative.62 Probably, the routine use of pediocin
PA-1 at concentrations not high enough to eradi-
cate all Listeria cells may result in emergence of
populations resistant not only to pediocin but also
to other closely related bacteriocins.63 The effect
of pediocin was higher when the initial Listeria
population was lower,62 a fact confirmed by a
later study that showed complete inhibition of
Listeria cells on refrigerated chicken meat by
pediocin treatment.64 These results emphasize the
importance of effective measures to prevent or
minimize food contamination.
Noerlis and Ray65 described how a non-
pediocin producer P. acidilactici strain (obtained
after loss of the plasmid harbouring the pediocin
PA-1 operon) became resistant to this bacteriocin
while growing in its presence. However, this study
also indicated that the acquired resistance was a
transient trait because it was soon lost after subcul-
turing (five subcultures) in a pediocin PA-1-free
medium. Similarly, Dykes and Hastings61 studied
the fitness costs associated with class IIa bacterio-
cin resistance in one L. monocytogenes strain and
found that the resistant strain had a lower growth
rate than the sensitive one in monocultures, and,
furthermore, that resistant cells were unable to in-
vade populations of the sensitive variants when
grown in mixed cultures. The authors concluded
that this specific class IIa bacteriocin resistance
was unlikely to become stable in natural popula-
tions of that particular L. monocytogenes strain.
However, this study may not reflect the general
situation because only one resistant strain was tested.
In contrast, the resistance to other LAB bacterio-
cins has been shown to be stable during at least 10
generations in the absence of contact with bacterio-
cins.66
Involvement of cell wall constitution and mem-
brane lipid composition in acquired bacteriocin
resistance has been suggested frequently.67-70 The
fact that stability of the resistance phenotype can
vary and may or may not be lost after subculturing
in the absence of the bacteriocin indicates that a
more general adaptive response may also be in-
volved in trained bacteriocin resistance.18 Bennik
et al.18 studied the relationships between mem-
brane lipid properties and the effect of pediocin
PA-1 and nisin on glycolysis, intracellular ATP
pools, and membrane potential of whole LAB cells.
Their results indicate that not only membrane lipid
composition, but also overall membrane constitu-
tion may play an important role in determining
LAB susceptibility toward these bacteriocins. These
authors suggested that although LAB strains with
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a natural high resistance toward a bacteriocin can-
not avoid the membrane insertion of bacteriocin
monomers, the overall composition of the mem-
branes may preclude the formation of pores with
sufficient diameters and lifetimes to cause cell death
(see mode of action).
Combination of pediocin PA-1 with other bac-
teriocins may constitute one approach to avoid the
growth of resistant cells. A mixture of nisin and
pediocin PA-1 was bactericidal to more cells in an
initially sensitive population, probably because cells
resistant to one bacteriocin were killed by the other.71
The combination killed more cells of two LAB and
two L. monocytogenes strains than each bacterio-
cin individually. In addition, the mixture inhibited
growth of all clostridial strains tested for up to 28
days, while pediocin or nisin alone produced vari-
able results. Recently, the additive effect of apply-
ing pediocin PA-1 in combination with bacterio-
cins belonging to unrelated classes has been
reported,72 demonstrating that, in addition to nisin
A, it can acts synergistically with lacticin 481,
lacticin B, or lacticin F. In contrast, when pediocin
PA-1 was combined with other class IIa bacterio-
cins, no synergistic effects were observed.26
The fact that pediocin PA-1 is, structurally and
functionally, completely unrelated to nisin, lacticin
481, lacticin B, or lacticin F may have practical con-
sequences. Different authors59,66 have reported that
although L. monocytogenes mutants with spontane-
ously acquired resistance to one class II bacteriocin
also displayed cross-resistance to other members of
this bacteriocin class, their sensivity to nisin had not
been affected. Sakacin P (a class IIa bacteriocin)
sensitivity among 22 strains of L. monocytogenes
directly correlated with the pediocin PA-1 sensitivity
of the strains. In another study,63 Listeria cells surviv-
ing nisin action were pediocin PA-1 resistant, while
pediocin PA-1 survivors remained susceptible to the
lantibiotic. The beneficial synergistic effects resulting
from the combination of unrelated LAB bacteriocins
can be exploited to extend their potential application
in the food industry.
D. Mode of Action
The bactericidal mode of action of pediocin
PA-1 on sensitive cells involves three basic steps:
pediocin binding to cytoplasmic membranes, in-
sertion of bacteriocin molecules in the membranes,
and formation of the poration complex. This pro-
cess finally leads to cell death that may occur with
or without cell lysis, probably depending on con-
comitant activation of the cell autolysins. For a
review on the mechanism of action of pediocin
PA-1 see Reference 73.
Initially, Gonzalez and Kunka8 showed that
pediocin-sensitive or pediocin-insensitive Gram-
positive cells adsorbed comparable levels of the
bacteriocin and concluded that the specificity of
pediocin PA-1 was at least not enterely dependent
on the presence of specific receptor sites in sensitive
cells, and that pediocin might have a high surface
binding capacity responsible for the unlethal bind-
ing to insensitive bacteria. Bhunia et al.54 reported
that the bacteriocin did not bind to the cell surface of
Gram-negative bacteria. Although the presence of
lipoteichoic acid in the cell wall of Gram-positive
bacteria and its absence in Gram-negative bacteria
could explain this differential adsorption ability, it
did not provide any explanation for the existance of
sensitive and insensitive Gram-positive bacteria.
These authors54 also described how pediocin PA-1-
treated sensitive cells lost intracellular K+ ions and
ultraviolet absorbing material became more perme-
able to ONPG and in some cases lysed.
The proton motive force (PMF) constitutes a
key parameter in the understanding of the mode
of action of LAB bacteriocins because it is re-
quired for many of the cells energy-dependent
metabolic processes. The PMF is the result of the
electrochemical gradient of protons across the
bacterial cytoplasmic membrane and is composed
of the membrane potential (∆ψ) and the pH gra-
dient (∆pH).74 The development of artificial mem-
brane systems and techniques that allow the sepa-
rate study of both components of the PMF have
enabled the investigation of the effects of differ-
ent bacteriocins, including pediocin PA-1, on PMF.
Christensen and Hutkins13 provided the first evi-
dence for the involvement of PMF in the mecha-
nism of action of pediocin PA-1. Pediocin caused
a concentration-dependent dissipation of the PMF
of L. monocytogenes Scott A cells. In addition,
the peptide increased the membrane permeability
of Listeria cells to protons, which agrees with a
dissipation of the pH gradient.
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These results, together with those obtained
with nisin,75-79 lactococcin A80, and lactococcin
B,81 led Bruno and Montville82 to hypothesize that
LAB bacteriocins employ a common mechanism
of action based on the dissipation of the PMF of
sensitive cells. To obtain further evidence, these
authors82 also investigated the influence of
pediocin PA–1, nisin, lactacin F, and leuconocin
S on the PMF of L. monocytogenes Scott A cells.
During the assay period, the Listeria population
decreased by 4 orders of magnitude after the ad-
dition of pure pediocin (20 µg ml–1) to the cul-
tures. Additionally, the residual ∆ψ (-30 mV) was
insufficient for culture viability. Energized cells
lost their PMF in a concentration-dependent man-
ner, while the ∆pH component was dissipated by
a pediocin concentration lower than that required
to eliminate ∆ψ. PMF collapse led to growth
inhibition and death because of the low intracel-
lular ATP levels and the inability to carry out
active transport of nutrients and to maintain suf-
ficient concentrations of cofactors, such as K+ and
Mg2+. Pediocin PA-1, lactacin F, and leuconocin S
acted in an energy-independent manner, in con-
trast with the energy-dependent mode of action of
nisin, a bacteriocin that seems to require a thresh-
old membrane potential for activity.82-83
The independent studies of Bruno and
Montville82 and Chikindas et al.25 indicated that
pediocin PA-1 formed voltage-independent pores
on the cytoplasmic membranes of target cells, a
process that dissipated the transmembrane elec-
trical potential, inhibited amino acid transport and
caused an efflux of small ions. Their data also
indicated that the pediocin concentration deter-
mined the size exclusion limit of the pores since
more pediocin was required to release compounds
having higher molecular weights (up to 9400).
Although pediocin (in vitro and at high concen-
tration) worked in the absence of PMF, the possi-
bility that in vivo PMF could increase the effi-
ciency of low pediocin concentrations on the target
membranes was not excluded. On the basis of
these and previous results, the authors proposed a
model for the mechanism of action of pediocin
PA-1. Initially, pediocin molecules would
nonspecifically adhere to the cell surfaces, fol-
lowed by specific binding to receptor components
of the cytoplasmic membrane. Then, pediocin
molecules would insert into the membrane, ag-
gregate and form oligomeric structures, leading
to hydrophilic pores through which ions and small
molecules would be released from sensitive cells
and, ultimately, to cell death. However, in the
same study,25 it was found that pediocin binds and
inserts in E. coli lipid vesicles with a high content
of zwitterionic phospholipids but without a pro-
tein receptor.
A study on the in vivo effect of pediocin PA-
1 on L. monocytogenes confirmed that, concomi-
tant with cell death, the bacteriocin induced deple-
tion of cytoplasmic ATP and irreversible K+ and
phosphate efflux.84 Pediocin PA-1 depleted 90%
of cytoplasmic ATP when only 25% phosphate
efflux had occurred, which indicated that loss of
ATP was due to attempts of the cell to maintain
PMF rather than its inability to produce ATP
because of phosphate loss. In contrast, nisin causes
simultaneous total ATP depletion and phosphate
efflux.85-86
Chen et al.28 characterized the physicochemi-
cal interactions of pediocin PA-1 with target
membranes using two-lipid vesicle models, one
based on total L. monocytogenes lipids and the
second on synthetic phospholipids. The antimi-
crobial peptide caused a time- and concentration-
dependent release of carboxyfluorescein (CF) from
the vesicles. The CF efflux rates were higher in
acidic that in neutral or alkaline conditions and
depended on both pediocin and lipid concentra-
tions. Although pediocin PA-1 was able to
permeabilize the membrane of Listeria lipid
vesicles in the absence of ∆ψ, the presence of a
transmembrane potential (inside negative) in-
creased the CF efflux rate by 88%. In vivo and
in vitro energy-enhanced action has been previ-
ously reported for bavaricin MN, another class IIa
bacteriocin, using the same lipid vesicle model.87
Generation of ∆ψ could have stimulated the for-
mation of more and bigger pores on the target
membranes.28 The fact that both lipid vesicle sys-
tems were devoid of membrane protein receptors,
together with the pediocin concentration-depen-
dent CF leakage, strongly suggested that no pro-
tein receptor was required for the recognition and
binding of pediocin PA-1 to the membrane of
sensitive cells. Instead, the bacteriocin molecules
could have recognized specific membrane lipids
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and/or established electrostatic interactions with
the phospholipid head groups.
As anionic phospholipids are the principal
components of L. monocytogenes membranes,88
Chen et al.28 subsequently characterized the bind-
ing of pediocin and pediocin fragments to vesicles
of phosphatidylglycerol by using tryptophan fluo-
rescence as a probe. It is possible to differentiate
tryptophan residues bound to membranes from
those in peptide molecules in an aqueous solution
because spectral parameters of its fluorescence
emission change with environmental polarity. The
results revealed that at least one tryptophan resi-
due of pediocin PA-1 was inserted into the an-
ionic membranes. This work also provided the
first evidence fot the key role that electrostatic
interactions between putative positively charged
pediocin patches and the negatively charged phos-
pholipid heads of the membranes play in the ini-
tial binding of the bacteriocin to target mem-
branes.
A further study89 revealed that affinity of
pediocin PA-1 for phospholipid vesicles increases
as the content of negatively charged phospholip-
ids is higher. In addition, the relative dissociation
constant for the peptide-lipid interaction was
higher when the anionic lipid content of the
vesicles decreased. This fact reflected the anionic
lipid dependency of the initial binding to the
membrane and supported the electrostatic inter-
action model of binding. Similar results have been
obtained for the lantibiotics epilancin K783 and
nisin.83,90 In addition to the initial unspecific elec-
trostatic interactions, there are important specific
interactions between the C-terminal half of
pediocin PA-1 and the target cells,24 particularly
within the fragment spanning residues 20 to 3430
(see structure-funcion relationships).
Bennik et al.18 reported that the exposure of
sensitive and insensitive LAB strains to pediocin
PA-1 resulted in a similar concentration-depen-
dant dissipation of ∆ψ, but the perturbation of the
cytoplasmic membrane caused rapid ATP deple-
tion only in the sensitive cells. These authors
suggested that not only membrane fluidity (re-
lated to lipid composition), but overall membrane
composition would influence the pore-forming
activity of bacteriocins, as membrane proteins
may affect lipid ordering.
E. Structure-Function Relationships
Despite the fact that class IIa bacteriocins
have similar primary structures, their antimicro-
bial spectra show differences greater than what
would be expected from the interaction between
the cationic peptides and the membrane lipids.5
Therefore, establishment of structure-function
relationships constitutes one of the major chal-
lenges in bacteriocin research. To facilitate the
understanding of this section, Figure 1 shows a
schematic representation of the pediocin PA-1
structure-function relationships that are (puta-
tively) known at present.
Several groups have described the loss of
pediocin PA-1 antimicrobial activity as a conse-
quence of DTT reduction of its disulfide bonds.25,73
DTT-induced reduction had only a moderate effect
on curvacin A and sakacin P activities.26 In these
bacteriocins only the equivalent of the first pediocin
PA-1 disulfide bond (C9-C14) is present. Thus, the
second disulfide bond (C24-C44) in pediocin PA-1
seems to be essential for the biological activity of
the peptide. This has been shown for the equivalent
C25-C43 disulfide bond in the class IIa bacteriocin
divercin V41.91 The fact that pediocin PA-1 and
enterocin A (both with two disulfide bonds) are
more active than curvacin A and sakacin P (with
only one bond) may be due, at least partly, to the
extra disulfide bond.26 These studies suggest that
the conserved bond is important but not crucial for
antimicrobial activity. Similar findings have been
reported with carnobacteriocin B292 and leucocin
A,93 but not with mesentericin Y105.94 In fact, the
activity of a mesentericin variant, which had the C9
and C14 residues substituted by serine residues, was
notably lower than that of the native peptide. Some
authors claim that both disulfide bridges are essen-
tial for pediocin PA-1 activity because of their
supposed role in the maintenance of a conforma-
tion compatible with activity.83,94
The primary structure of class IIa bacterio-
cins may be divided into two functional regions,
the well-conserved and hydrophilic N-terminal
half and the more heterogeneous and relatively
hydrophobic C-terminal half.24 Fimland et al.24
synthesized four hybrid bacteriocins in which the
modules corresponding to pediocin PA-1 (Ped),
sakacin P (Sak), and curvacin A (Cur) had been
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exchanged. The four hybrids (Ped-Sak, Sak-Ped,
Cur-Sak, and Sak-Cur) were biologically active.
The hybrid bacteriocin had an inhibition spec-
trum that was similar to that of the bacteriocin
from which its C-terminal module was derived
and different from the bacteriocin that provided
the N-terminal part. Therefore, the C-terminal
module of class IIa bacteriocins plays an impor-
tant role in determining the specificity of target
cells. A later report30 indicated that a 15-mer pep-
tide fragment derived from pediocin PA-1 (resi-
dues 20 to 34) interfered specifically with pediocin
PA-1 target cell interaction, leading to inhibition
of the pediocin antimicrobial activity. The frag-
ment also significantly affected enterocin A ac-
tivity but not that of other closely related bacte-
riocins (sakacin P, curvacin A, and leucocin A).
Among these bacteriocins, pediocin PA-1 and
enterocin A have the highest degree of homology
in the region spanned by the fragment and, addi-
tionally, are the only ones with a cysteine residue
in this region. Apparently, inhibition of pediocin
PA-1 activity by the fragment was due to specific
interference of the fragment with pediocin-target
cell interactions and not merely to hydrophobic
interactions between these two elements. Recently,
site-directed mutagenesis studies of pediocin PA-1
and sakacin P have been performed to elucidate
the structural basis for the differences observed in
their respective activities and target cell
specifities.46 By making the primary structure of
sakacin P more pediocin PA-1-like, it has been
shown that the extra disulfide bond C24-C44 of
pediocin PA-1 contributes to both temperature
stability and to widening the target cell spectrum.
The results also support the previous suggestion24,30
that the variable C-terminal part of pediocin-like
bacteriocins interacts with the hydrophobic part
of the membrane, being an important determinant
of target cell specificity.
Chen et al.28 observed that K11 and H12 resi-
dues were essential in the bacteriocin binding to
phospholipid vesicles. At pH 6, two pediocin frag-
ments, N15 (residues 1 to 15) and N8-15 (resi-
dues 8 to 15), bound strongly to lipid vesicles and
the binding behavior of N15 was comparable to
that of pediocin PA-1. However, the binding abil-
ity displayed by fragment N7 (residues 1 to 7),
which do not contain the positively charged resi-
dues, was only weak. In addition, no binding was
observed at the same pH value using the mutant
Nm8-15, in which K11 and H12 had been replaced
by uncharged residues (I11 and L12, respectively).
Binding of the fragments containing this putative
positive patch decreased by adjusting the pH to 8,
probably because of the deprotonation of the his-
tidine residue.
The finding that an in-frame fusion between
the functional mature domain of pediocin PA-1
and the C-terminus of the secretory protein mal-
tose-binding protein (MBP) retained antimicro-
bial activity96 suggests that the bacteriocin
N-terminal region does not span the phospholipid
bilayers of the target cells. The same study re-
vealed that the class IIa consensus sequence is
essential for pediocin PA-1 activity because its
deletion resulted in loss of the activity.
Miller et al.97 generated a collection of 18
pediocin mutants, 17 of which were obtained by
random PCR mutagenesis of the pediocin PA-1
structural gene. They were produced and secreted
as MBP-fusion proteins. Eight mutants (N5K,
C9R, C14S, C14Y, C24S, G37E, G37R, and
C44W) were completely inactive, while nine
(K1N, W18R, I26T, M31T, A34D, N41K, H24L,
K43N, and K43E) retained some activity, ranging
from <1 to 60%. However, the activity of the
remaining mutant (K11E) was around 2.8-fold
higher than that of the MBP-pediocin PA-1 chi-
meric protein. The results showed that the four
cysteine residues were required for activity. The
disulfide bond may be essential to maintain the
conformation of the sequence G10-K11-H12-S13 that
constitutes the apex of the β-hairpin previously
proposed by Chen et al.27 and that exhibited weak
homology to several known types of consensus
β turns. Among the four lysine and three histidine
residues of pediocin PA-1, three residues (K1,
H42, and K43) seemed to be particularly important
for activity.96 The substitution K1N resulted in an
almost complete inactivation of bacteriocin activ-
ity, while the substitutions H42L, K43N, and K43
reduced its activity by 40 to 80%. Therefore, K1
may play an essential role in membrane binding
while that of H42 and K43 would be secondary.
These results97 show that protein engineering of
class IIa bacteriocins could be a feasible way to
improve their activity, stability, and/or solubility.
103
Miller et al.97 submitted the pediocin C-termi-
nal half to hydrophobicity analysis in order to
locate apolar sequences that could participate in
membrane binding. In this region, the stretch com-
prising residues I25 to G37 had enough hydropho-
bicity to allow its location inside a phospholipid
bilayer if simultaneous membrane insertion of
two or more molecules would occur, something
that probably does occur during the formation of
the poration complex.
It has been suggested that the C-terminal
module of pediocin PA-1 would become
amphiphilic, and therefore would permit the for-
mation of a poration complex if it adopted a trans-
membrane α-helical secondary structure.24 How-
ever, adoption of such a structure seems
incompatible with the disulfide bond C24–C44
formed by residues located at the begining and
end of such an α-helix.26 The effect of this disul-
fide bridge in the structure of the C-terminal re-
gion will have to be determined before drawing
any conclusion on the role of amphipathicity, if
any, in the formation of the poration complex.97
IV. BIOSYNTHESIS
A. Location of the Genetic Determinants
The genetic determinants for the biosynthesis
of pediocin PA-1 are plasmid encoded in all pro-
ducing strains isolated to date.8,11,15,17-19,23,34,98,99 In
several strains, the sizes, organization, and re-
striction profiles of the various pediocin-encod-
ing plasmids are similar.17,100 It has been shown
that the plasmids responsible for production in
P. acidilactici H can be transferred intragenerically
by conjugation.34
B. Organization of the Pediocin PA-1
Operon
Pediocin PA-1 biosynthesis involves a DNA
fragment of approximately 3.5 kb, comprising the
four genes pedA, pedB, pedC, and pedD.22 Each
gene is preceded by a ribosome binding site (RBS),
starts with the AUG start codon (except pedB,
which starts with a UUG codon), and finishes
with a UAG stop codon22 (Figure 2). The four
genes are organized in a single operon, governed
by a promoter located directly upstream of pedA.
The sequences of its –35 (TTGACA) and –10
(TAGAAT) regions, separated by 18 bp, are in
close agreement with the consensus sequences of
constitutive promoters of Gram-positive bacte-
ria.22,101 Two transcripts are produced from the
pediocin PA-1 operon. The most abundant mes-
senger has a size of approximately 1.2 kb and
covers pedABC, while the second transcript has a
size of 3.5 kb and corresponds to the pedABCD
genes.55 There are rho-independent transcriptional
terminators directly downstream of the pedC and
pedD genes55,102 (Figure 2).
The production of some class II bacterio-
cins has been reported to be a quorum sensing
phenomenon.103 The process is transcription-
ally regulated through a signal transduction
system integrating an induction factor (peptide
pheromone), a histidine protein kinase and a
response regulator. The induction factor is a
bacteriocin-like peptide with a double-glycine
leader but without bacteriocin activity.4 There
is no evidence for the existence of a similar
system for the activation of transcription of the
pediocin PA-1 genes.
C. The pedABCD Genes and Their
Products
The pediocin PA-1 structural gene (pedA) en-
codes a 62 amino acid pediocin precursor called
prepediocin PA-1. The 18 N-terminal residues of
prepediocin constitute the leader sequence, which
is removed concomitantly with secretion, resulting
in mature pediocin PA-1, a peptide of 44 amino
acids. The pediocin leader belongs to the group of
the “double-glycine” leaders, which is found in
most nonlantibiotic and some lantibiotic LAB
bacteriocins and also in colicin V from
E. coli. These leaders share the consensus sequence
L
-12S-11XXE-8L-7XXI-4XG-2G-1 with the two con-
served glycine residues at positions –1 and –2
constituting a common processing site, a fact re-
flected in the name of the group.3,104,105 Prepediocin
PA-1 is also biologically active,55 approximately






































































Marugg et al.22 suggested that the 112 amino
acid protein encoded by pedB could be involved
in immunity of the producing cells, because mu-
tational inactivation of this gene did not affect
pediocin PA-1 production in E. coli, a micro-
organism naturally insensitive to this bacteriocin.
Later, this hypothesis was confirmed as pediocin
PA-1 was not active against a previously sensi-
tive P. pentosaceus strain that had been trans-
formed with a plasmid carrying the pedB gene.55
In fact, the level of insensitivity of the resulting
strain was even higher than that of the parental
producer, probably because of the higher copy
number of the plasmid encoding pedB in the
transformant and/or because pedB was cloned
under the control of P32, a strong lactococcal
promoter.
Recently, several immunity proteins belonging
to pediocin-like bacteriocins were cloned behind
P32.107 Introduction of the different pediocin-like
immunity genes into a highly bacteriocin-sensitive
Lb. sakei strain resulted in a selective immunity
against the respective pediocin-like bacteriocins
tested. In general, low cross-immunity was observed;
however, PedB and the immunity protein for sakacin
P displayed complete cross-immunity despite the
degree of sequence similarity between these two
immunity proteins is lower than that observed be-
tween, for instance, PedB and the enterocin A im-
munity protein.107
The pedC gene encodes a 174 amino acid
protein (PedC), which is essential for pediocin
secretion in pediococci and E. coli,55 and belongs
to the group of so-called “accesory proteins” re-
quired for secretion processes involving ATP-
binding cassettes (ABC) transporters. Accesory
proteins are also called “membrane fusion pro-
teins” (MFP) because it has been postulated that
they may connect the inner and outer membranes
of Gram-negative bacteria to facilitate the pas-
sage of substrates.108 The PedC structure is simi-
lar to those of HlyD, a protein required for secre-
tion of the E. coli hemolysin A,109 and LcnD, a
protein involved in lactococcin A transport.110
Finally, pedD encodes PedD, a 724 amino
acid ABC transporter dedicated to pediocin secre-
tion through the membrane of the producing cells.
Inactivation of this gene leads to total loss of
antimicrobial activity because of lack of secre-
tion.22 The PedD sequence displays a high degree
of homology with sequences of many others ABC
transporters.105
D. Secretion and Maturation of Pediocin
PA-1
The secretion and maturation processes of
pediocin PA-1 depend on the membrane proteins
PedC and PedD, which together form a type I
secretion system.111 In this sec-independent sys-
tem, the substrate is directly secreted from the
cytoplasm of the cell to the extracellular environ-
ment. As type I secretion systems are specific for
a protein or family of closely related proteins,
they are often called “dedicated” transport sys-
tems.112,113
A typical ABC transporter probably functions
as an homodimer, each part consisting of a hydro-
phobic integral membrane domain and two ATP-
binding domains, which can be fused in a
multidomain protein.113 All transporters dedicated
to “double glycine” prebacteriocin secretion have
an N-terminal cytoplasmic extension that forms
the proteolytic domain responsible for removal of
the leader peptide. In the N-terminal part of these
bacteriocins transporters there are two conserved
motifs, the cysteine motif (QX4D/ECX2AX3MX4Y/
FGX4I/L) and the histidine motif (HY/FY/VVX10I/
LXDP).4,105 Based on the work of Havarstein et
al.,105 with lactococcin G, the following hypothesis
for the export of pediocin PA-1 can be made.4 The
proteolytic domain of PedD binds to prepediocin
PA-1. Then, hydrolysis of ATP induces conforma-
tional changes in PedD leading to an integrated
process in which removal of the pediocin leader
concomitantly occurs with pediocin translocation
across the cytoplasmic membrane. In fact, expres-
sion of only the N-terminal 172 amino acids of
PedD in E. coli cells producing prepediocin showed
that this domain was enough and essential for
prepediocin processing.55 Under these circum-
stances, mature pediocin could only be found intra-
cellularly, which suggests that the cleavage pro-
cess can be uncoupled from secretion.
Apart from the extended N-terminal domain
responsible for the processing of the prebacteriocin
into the mature form, the ABC transporters dedi-
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cated to double glycine leader bacteriocins prob-
ably also differ from the earlier described “classi-
cal” ABC transporter proteins in their membrane
topology. It has been reported that the lactococcin
A-dedicated ABC transporter (LcnC) has four
transmembrane segments (TMSs) instead of the
six typically present in the classical ones.113
The accesory protein (PedC) has a membrane
topology similar to LcnD, the lactococcin A
accesory protein. Both are bitopic proteins with a
short N-terminal cytoplasmic part, a transmem-
brane segment and a large extracellular C-termi-
nal part.113 Venema et al.55 speculated that PedC
may be involved in channel formation between
the cytoplasmic membrane and the cell wall of
pediocin-producing cells. A similar role has been
proposed for LcnD.113 Recently, LcnD was shown
to be present in two forms: a 52-kDa full-length
form, totally contained in the cytoplasmic mem-
brane, and a smaller form (LcnD*, 38 kDa) that is
present mainly in the cytoplasm with a small
amount localized in the membrane.114 LcnC and
LcnD are organized in a membrane-associated
complex in which LcnD, probably present as a
dimer, is able to interact with LcnD* and LcnC.114
In addition, LcnC cross-links with a small peptide
that could be the bacteriocin lactococcin A.114
E. Heterologous Expression of ped
Genes
Heterologous expression systems are usually
employed to elucidate the function of recombi-
nant proteins or peptides or to achieve levels of
production higher than those of the native sources.
They are also useful to produce a protein or a
peptide by specific species, or strains, that are
better adapted than the native producer to the
environment where application of the proteina-
ceous compund is desired.
Escherichia coli has long been the primary
prokaryotic host for cloning genes and expressing
recombinant proteins because it is well character-
ized, many of its biological processes are under-
stood and there are many genetic tools readily
available for its manipulation.115 Regarding
pediocin PA-1, transformation of E. coli strains
with a plasmid containing the pediocin operon
resulted in correct expression of the pediocin genes
since the transformants produced zones of inhibi-
tion on the indicator lawn.22 As bacteriocin activ-
ity was also observed in cell-free supernatants,
the authors concluded that pediocin was, most
probably, secreted by the cells. E. coli mutants
with a mutated pedD gene did not secrete pediocin,
which confirmed the role of PedD in pediocin
transport.
In the absence of pedC and pedD, mature
pediocin PA-1 can be secreted in an active form
when fused to the MBP C-terminus and therefore
coupled to the E. coli sec machinery.96 The chi-
meric protein was released into the culture me-
dium because it was expressed in a leaky E. coli
host in which the gene encoding the outer mem-
brane murein lipoprotein had been disrupted.
Although there is a wealth of tools for ex-
ploiting E. coli for heterologous gene expression,
other bacteria can offer advantages either for cy-
toplasmic production, secretion, or surface dis-
play.116 Some LAB species, such as L. lactis are
proving to be very versatile, and continuing basic
research on gene expression in these organisms
will increase their utility as alternative hosts for
heterologous gene expression. In addition, many
LAB species or strains are food-grade organisms,
making them potentially useful for the heterolo-
gous (in situ) production of commercially impor-
tant proteins or peptides.115
An attractive possibility for heterologous pro-
duction of pediocin PA-1 is to exploit the signifi-
cant amino acid homologies in both the leader
peptides and dedicated transporters of most class
II bacteriocins, some lantibiotics, and also colicin
V produced by E. coli.55,104,105 Allison et al.117
showed that both peptides of the two-component
lactacin F complex can use the bacteriocin secre-
tion machinery of Carnobacterium piscicola
LV17, a strain that produces carnobacteriocins A,
BM1, and B2.118 The fact that the leaders of these
carnobacteriocins and both lactacin F peptides
share the highest degree of homology among class
II bacteriocins may have facilitated the secretion
of the lactacin F peptides in this heterologous
host. van Belkum et al.119 recently demonstrated
the flexibility of the translocation apparatus by
exchanging the leader peptides of different class
II bacteriocins. Gene fusions were generated in
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which sequences encoding the leader peptides of
leucocin A, lactococcin A, and colicin V were
fused to divergicin A, a bacteriocin that is se-
creted through the sec pathway.120 The different
leader peptides were able to direct the secretion of
divergicin in Leuconostoc gelidum, L. lactis, and
E. coli, respectively (i.e., the homologous hosts).
Furthermore, certain leader-translocator combi-
nations led to heterologous production of
divergicin. Colicin V was also secreted from
L. lactis when it was fused to the leucocin A
leader and the lactococcin A secretion machinery
was used. However, in some cases, the leader
peptides were unable to direct divergicin secre-
tion, suggesting that the various components of
the translocation apparatus of class II bacteriocins
are not universally interchangeable. It may be that
the hydrophobicity of the heterologous peptide
plays an important role in the secretion process.119
Although the system LcnC/LcnD can secrete a
great variety of bacteriocins that differ quite dras-
tically (like lactococcins A, B, and M/N),111 its
inability to direct secretion of leucocin A in L.
lactis has also been reported.121
Pediocin PA-1 is a bacteriocin with a broad
inhibitory spectrum and is particularly effective
in preventing the growth of L. monocytogenes, a
major concern in the dairy industry because it can
grow in a variety of dairy products at low tem-
perature and pH. However, with the exception of
Lb. plantarum WHE 92,17 all pediocin PA-1-pro-
ducing bacteria so far isolated are pediococci,
organisms usually associated with vegetable and
meat substrates but poorly adapted for growing in
milk and dairy products. Therefore, the produc-
tion of pediocin PA-1 in strains of dairy origin is
highly desirable.
The four ped genes were cloned into a
lactococcal vector and introduced into L. lactis
IL1403, a pediocin PA-1-resistant, plasmid-free
strain that does not produce bacteriocin but har-
bors chromosomal genes analogous to those en-
coding the lactococcin A secretion apparatus (lcnC
and lcnD).55,122,123 Secretion of pediocin PA-1,
directed by its own leader sequence, was detected
only when the ped operon was under the control
of the strong lactococcal promoter P32. Even under
these conditions, the pediocin yield was less than
1% of the production level by the Pediococcus
parental strain. It was possible to increase the
relative pediocin PA-1 production level to ap-
proximately 50% in L. lactis LL108, a derivative
of L. lactis MG1363, by increasing the copy num-
ber of the plasmid-encoded ped operon. In the
same work,122 a recombinant P. acidilactici strain
was obtained that produced and secreted both
active pediocin PA-1 (an amount similar to that of
the parental pediococcal strain) and lactococcin A
(twofold lower than that of the parental lactococcal
strain).
Pediocin PA-1 and lactoccoccin A are both
class II bacteriocins and, hence, likely candidates
for expression and secretion in L. lactis via heter-
ologous translocators.38 A hybrid gene specifying
an in-frame fusion of the lactococcin A leader and
pediocin PA-138 was introduced in L. lactis IL1403
(LcnC’+, LcnD’+). The L. lactis IL1403 derivative
produced extracellular pediocin activity, but the
production level was approximately 25% of that
of the parental pediococcus strain. Significant
reductions in the yield of lactococcin A expressed
in IL1403 have been described previously.36,80
These reductions may be attributed to the low
copy number of the chromosomal lcnC’D’ genes123
and/or to differences in the lactococcin A translo-
cation apparatus,119,123 resulting in less efficient
secretion.
Enhanced heterologous production of pediocin
PA-1 was obtained by introducing the lcnC and
lcnD genes into the lactococcin A leader-pediocin
PA-1 expression system previously developed.39
When lcnC and lcnD were present on the same
plasmid (a pSH71 derivate, 50 to 60 copies per
cell124) as the hybrid gene, one of the resulting
L. lactis IL1403 derivatives attained pediocin PA-
1 levels similar to that of the natural producer
P. acidilactici 347. The yield of LcnC/D-medi-
ated translocation of pediocin PA-1 was strongly
influenced by the plasmid dosage and by the par-
ticular lactococcal strain employed as a produc-
tion host. It has also been demonstrated that het-
erologous production of other class II bacteriocins
can increase at least 10-fold when the dedicated
lcnC and lcnD genes are included in equivalent
lactococcal expression systems.80,123 In the same
study,39 L. lactis strains with the ability to express
and secrete nisin A together with pediocin PA-1
were also constructed, which represents a first
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step in the construction of LAB strains that co-
produce two or more well-characterized wide-
spectrum bacteriocins. Recently, low-level
coproduction of the nonsynergistic class IIa bac-
teriocins pediocin PA-1 and enterocin A in
L. lactis IL1403125 and production of a variable
amount of pediocin PA-1 in E. coli, L. lactis,
Streptococcus thermophilus, and Enterococcus
faecalis have also been achieved.126 The cells were
transformed with shuttle vectors containing the
four genes of the ped operon (without its own
promoter) behind the S. thermophilus promoter
STP2201.
Yeast, especially Saccharomyces cerevisiae
and Pichia pastoris, are major hosts employed in
the expression of heterologous proteins of high
quality in the biopharmaceutical, industrial, and
academic environments because they combine
well-known techniques for the molecular manipu-
lation of prokaryotes with the authenticity of eu-
karyotic systems.127 Frequently, excessive amounts
of sulfur dioxide and other chemical preserva-
tives are used to prevent growth of undesirable
bacteria during the making of wine, beer, and
other beverages. This practice affects the quality
of the end-products and raises increasing con-
sumer concerns. Schoeman et al.128 investigated
the feasibility of controlling spoilage bacteria
during yeast-based fermentations by expressing
pediocin PA-1 in S. cerevisiae. To achieve this
objective, the pedA gene was inserted into a yeast
expression/secretion cassette in which expression
of pedA was under the control of the yeast alcohol
dehydrogenase I gene (ADH1) promoter and ter-
minator, and the secretion of the bacteriocin was
directed by the secretion signal of the yeast mat-
ing pheromone α-factor (MFα1S). The construct
was introduced as a multicopy plasmid in
S. cerevisiae. Northern blot analysis confirmed
that pedA was efficiently transcribed, while bio-
logically active bacteriocin was detected in a bio-
assay. However, the heterologous peptide was
present in relatively low levels in the yeast culture
supernatant because most of the bacteriocin mol-
ecules were attached to the yeast cells. Production
of extracellular pediocin PA-1 by recombinant
yeast strains may be optimized by enhancing pedA
gene expression as well as by increasing the
secretability of the recombinant bacteriocin. It
has been reported that S. cerevisiae is often lim-
ited as an expression system by low yields, while
other yeast species, such as P. pastoris or
Hansenula polymorpha, retain all the advantages
of S. cerevisiae and provide a reliable means of
achieving greatly elevated yields.129-131
The development of systems for heterologous
production of pediocin PA-1 and other bacteriocins,
either using ABC-transporters or sec-dependent se-
cretion systems, may contribute to overcome prob-
lems that bacteriocin-producing starter cultures of-
ten face in food processes, such as poor adaptability,
low production, or genetic instability. In addition,
these heterologous systems could be used for pro-
duction of hybrid bacteriocins or pediocin-like bac-
teriocins with improved properties obtained by pro-
tein engineering. Overexpression of the ped genes
by use of food-grade inducible systems, like those
based on the PnisA promoter132-135 or the salt-induc-
ible Pgad promoter136,137 could be another interest-
ing approach. Recently, enhanced secretion of
pediocin PA-1 was achieved in a L. lactis strain
following induced expression of pedC and pedD
behind the Pgad promoter.138
F. Factors Affecting Pediocin PA-1
Biosynthesis
The amount of pediocin PA-1 produced is
very strain-dependent, although the variability
seems to be less than that observed, for instance,
among different nisin- or leucocin Lcm1-pro-
ducing strains.139 Under the same conditions,
P. acidilactici H produced more pediocin than
strains E, F, and M,100 which was attributed to
the higher growth rate of strain H and/or to the
higher genetic stability of the plasmid on which
the pediocin operon is located in that strain. The
level of pediocin PA-1 produced by
Lb. plantarum WHE 92 was higher than that of
P. acidilactici H under optimum culture condi-
tions, although production per cell was not re-
ported.17 Recently, specific antibodies were used
to determine the concentrations of pediocin
PA-1 in the supernatants of five independently
isolated P. acidilactici strains.41 While four of
the strains produced similar amounts (ranging
from 1946 to 2200 ng ml–1), the bacteriocin con-
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centration in the supernatants of the remaining
strain was significantly lower (12 ng ml–1).
Pediocin PA-1 production is higher when the
producing pediococci are grown at 30 to 37°C50 in
media that allow the development of a high cell
mass and a high acidity, such as MRS or
TGE.50,139,140 The addition to TGE broth of supple-
ments (tryptone, glucose, yeast extract) or comple-
ments (niacinamide, panthotenic acid, biotin) that
stimulate cellular proliferation notably increased
pediocin production, while production decreased
by incorporating buffering compounds.139
A clear reduction in the quantity of pediocin
produced either by P. acidilactici strains or
Lb. plantarum WHE 92 was observed when the
final pH of the medium exceeded 4.0.17,141 While
bacteriocin production by P. acidilactici H was
neligible when the pH of the medium was 5 and
ceased at pH 5.5, even at high cell densities,17,140
the activity of culture extracts from Lb. plantarum
WHE 92 remained constant independently of the
final pH value of the culture broth between pH 4.0
and 6.0 at pH and decreased only at pH 6.5.17 A later
study confirmed that the amount of pediocin PA-1
produced by Lb. plantarum WHE 92 at the end of the
exponential growth phase is independent of the pH of
the culture medium between pH 4.0 and 6.0.141
It has been suggested that processing of
prepediocin to active pediocin by pediococci takes
place efficiently only if the pH of the medium is
less than or equal to 5.0.139,142 Although this would
explain why pediocin production by P. acidilactici
decreases when the final pH of the culture is
higher than 5, it is not clear why that of
Lb. plantarum WHE 92 is not reduced up to pH 6.0.17
Culture pH may have played an important
role in the yield of pediocin PA-1 by the heterolo-
gous lactococcal host L. lactis FI9043, because
larger inhibition zones were generated from su-
pernatants of cultures grown in MRS broth (final
pH 4.6) than from those in GM17 broth (final pH
5.3).38
The highest pediocin yields can be obtained
by determining the optimal conditions for pediocin
production during pH- and temperature-controlled
batch cultures in a fermentor.141,143 Under such
conditions, batch cultures of P. acidilactici UL5-
T5 at 37°C and pH 5.5 yielded approximately 190
mg l–1 of pediocin.
V. TOXICITY
Pediocin-producing strains are found in a
variety of natural foodstuffs, such as meat prod-
ucts,8,10,19,34 dairy products,17 and vegetables.18
Therefore, they (and most probably pediocin too)
have been ingested by human consumers for cen-
turies without apparent adverse effects, which is
a first indication of low toxicty of this bacteriocin
toward eukaryotic cells. Additionally, treatment
of mouse myeloma cell cultures with pediocin
PA-1 did not affect cellular viability or morphol-
ogy,50 and no detrimental effects have been ob-
served after subcutaneous, intradermic, intrave-
nous, or intraperitoneal administration of this
bacteriocin (or fragments thereof) to mice and
rabbits14,40,41,144-146 or after prolonged ingestion by
humans of meat products made with the pediocin-
producing strain P. acidilactici H.147 Finally, the
intestinal microflora is probably unaffected by
pediocin PA-1 because of its inactivation by the
proteolytic enzymes of the digestive tract.
VI. IMMUNOLOGICAL PROPERTIES
In general, generation of antibodies against
bacteriocins may provide sensitive and specific
tools for the detection of producing strains and for
the quantification of the peptides in culture media
and food extracts by immunochemical as-
says.40,41,43,145,146,148-150 Moreover, antibodies may be
used in single-step purification methods based on
immunoaffinity strategies.44 Although highly spe-
cific immunochemistry-based methods have been
developed and routinely used as analytical tools in
many research areas, their impact in the bacterio-
cin research field has been marginal.149 Thus, iden-
tification and detection of bacteriocinogenic LAB
and bacteriocins has relied on the use of sensitive
but unspecific bioassay-based tests.
The two main difficulties encountered in rais-
ing antibodies against bacteriocins are the lack of
commercially available purified bacteriocins and
the need to couple them to proper carrier proteins
because of their low molecular masses (which make
them poorly immunogenic or nonimmunogenic).
In addition, some characteristics of class II LAB
bacteriocins such as hydrophobicity or the pres-
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ence of intrachain disulfide bonds may interfere
with the development of sensitive immunoassays.
Bhunia et al.144 evaluated the immunogenic
properties of partially purified pediocin by immu-
nizing mice and a rabbit and found that it was
unable to illicit an antibody response, even after
conjugation of the peptide to bovine serum albu-
min. Polyclonal and monoclonal antibodies against
pediocin were developed by immunizing mice for
12 weeks with pediocin conjugated to a polyacry-
lamide matrix.148 Among 230 hybridoma clones
generated after two fusions, two were found to
produce antibodies that in Western immunoblots
recognized this bacteriocin (detection limit: 10 µg
ml–1) but did not react with sakacin A, leuconocin
LCM1, nisin and pediocin A. Immunization of
mice with crude precipitates of pediocin PA-1 or
with pediocin bound to heat-killed Lactobacillus
plantarum cells failed to produce antibodies
against the bacteriocin. In colony immunoblot
assays, the monoclonal antibodies were used
to differentiate Ped+ and Ped– variants of
P. acidilactici RS2. Although monoclonal anti-
bodies could be very useful in developing quan-
titative assays for pediocin production, to date no
new developments have been reported from this
line of research.
Development of successful polyclonal and
monoclonal antibodies and immunoassay formats
have enabled the sensitive and specific detection
and quantification of nisin.43,44,149,150 Commercial
preparations of pure pediocin PA-1, unlike nisin,
are not available, and current pediocin PA-1 pu-
rification protocols do not allow purification of
the large quantities of peptide needed to carry out
cost-efficient immunization protocols. The use of
whole bacteriocins, either alone or conjugated to
carrier proteins may, if successful, lead to the
generation of unspecific polyclonal antibodies due
to cross-reactivity with consensus amino acid
sequences found in other bacteriocins, and espe-
cially among class IIa LAB bacteriocins.4,26,151
Short peptide fragments of proteins can be used to
generate antibodies that frequently recognize the
folded protein from which the peptide sequence
was derived,152 a fact that explains why antipeptide
antibodies have become important tools in many
research fields.153,154 Chemically synthesized frag-
ments selected from the amino acid sequence of
pediocin PA-1 could, thus, potentially facilitate
obtaining antibodies of predetermined specificity
for the recognition of the native peptide mol-
ecule.145
Recently, such polyclonal antibodies against
pediocin PA-1 have been generated by immuni-
zation of rabbits with a chemically synthesized
C-terminal fragment (PH2, residues 34 to 44)
conjugated to the carrier protein keyhole limpet
hemocyanin (KLH).40 The limits of detection of
pediocin PA-1 in MRS medium using these anti-
bodies were approximately 2.5, 1, 0.025 and
<0.025 µg ml–1 by immunodotting, noncompeti-
tive indirect ELISA (NCI-ELISA), competitive
indirect ELISA (CI-ELISA) and competitive di-
rect ELISA (CD-ELISA), respectively. All im-
munoassays and the slot-dot assay detected the
bacteriocin in the supernatant of the producer
P. acidilactici 347. The antibodies did not cross-
react with other bacteriocins, including other
members of class IIa LAB bacteriocins, and were
very useful in demonstrating heterologous pro-
duction of pediocin PA-1 in L. lactis.38,125
Pediocin PA-1-specific rabbit polyclonal an-
tibodies have also been generated with a synthetic
1 to 9-N-terminal fragment (PH1) conjugated to
the same carrier protein.41 In this case, the limits
of detection of pediocin PA-1 in MRS medium
were approximately 5, 0.5, 0.01, and <0.01 µg
ml–1 by protein slot-blotting, NCI-ELISA, West-
ern blotting, and CI-ELISA, respectively. The
amount of free pediocin required for 50% binding
inhibition was 0.1 µg ml–1 as determined by CI-
ELISA. In addition, results obtained with the same
assay clearly indicated that when pediocin, in-
stead of ovalbumin-conjugated pediocin, was used
as solid-phase antigen, the assay was notably
better. In contrast, pediocin did not efficiently
compete with the conjugate pediocin-horseradish
peroxidase for binding to antibody-coated
microtiter plate wells in CD-ELISA, confirming
the results of previous work145 and highlighting
the importance of the selection of proper immu-
noassays for bacteriocin detection. The PH1-KLH
polyclonal antibodies detected the peptide in the
supernatants of five pediocin-producing
P. acidilactici strains.41 However, it did not or only
slighty reacted with supernatants of LAB strains
producing enterocin A, enterocin P, sakacin P, or
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sakacin A, bacteriocins that contain the longer
(KYYGNGVxC) or shorter (YGNGVxC) con-
sensus amino acid sequence present in pediocin
PA-1. This result is not surprising because it has
been shown that, within a peptide fragment,
changes in a single amino acid residue can dras-
tically affect protein recognition.155
The conjugate PH2-KLH has also been used
to immunize mice in order to obtain a source of
pediocin PA-1 monoclonal antibodies. However,
among the hybridomas generated after three fu-
sions, none produced antibodies.146
VII. FOOD APPLICATIONS
Although frequently in vitro studies have
shown the high antimicrobial activity of pediocin
PA-1 against sensitive bacteria, particularly
L. monocytogenes strains, most food applications
of this bacteriocin have resulted in relatively
modest reductions of 1 to 3 log cycles in the
populations of potential foodborne pathogens.45
Therefore, deductions obtained from in vitro chal-
lenges should not be extrapolated to predict
pediocin efficacy in a food matrix.156 Factors that
may lead to a reduction of pediocin activity in
foods include those affecting the pediocin-pro-
ducing strain (such as inadequate environment,
spontaneous loss of the bacteriocin-producing
ability, phage infection, or antagonism by other
microorganisms) and those affecting the bacteriocin
action (such as emergence of bacterial resistance,
bacteriocin binding to food components, or poor
solubility or stability in the food substrate).45,156,157
Although the levels of bacterial population
reduction achieved by pediocin PA-1 in foods
may preclude its consideration as a primary pres-
ervation method, this bacteriocin and/or the pro-
ducing strains could be very useful as an addi-
tional safety factor contributing to the “hurdle” or
“barrier” approach for preservation of foods.7,45
In this kind of food preservation systems, the
combined effects of intrinsec (e.g., pH, heat treat-
ment, salt, sugar, chemical additives) and extrin-
sic (e.g., storage conditions) inhibitory barriers
work synergistically to extend storage life and
ensure the microbiological safety of foods.158
Currently, the incorporation of pediocin or other
LAB bacteriocins to this approach is attractive
because the range of minimally processed foods
available in the marketplace is rapidly increas-
ing.7
A. Meat and Meat Products
Kalchayanand159 studied the action of pediocin
PA-1 (1,400 AU ml–1) added to beef meat inocu-
lated with food-spoilage strains of Clostridium
laramiae, Lactobacillus spp., and Leuconostoc.
Subsequently, the meat samples were vacuum-
packaged and stored in refrigeration. Under these
conditions, the treated samples remained unal-
tered after storage for 12 weeks and the popula-
tion levels reached by the spoilage bacteria were
significantly lower in the samples containing the
bacteriocin than in the respective control samples.
Simultaneously, another study160 evaluated the
ability of pediocin PA-1 (500 to 5000 AU ml–1) to
prevent the adhesion of L. monocytogenes to irra-
diated beef meat and to decontaminate the meat
inoculated with 102 to 104 cfu g–1. Both strategies
reduced the populations of L. monocytogenes
between 1.2 and 2 log cycles, and the residual
bacteriocin activity was detected on the meat sur-
face for at least 28 days at 5°C.
Berry et al.161 employed the pediocin-produc-
ing strain P. acidilactici JD1-23 as starter culture
for the elaboration of meat products and found
that it provided a 2-log reduction in added
L. monocytogenes (106 cfu g–1) during summer
sausage production, which are results similar to
those obtained by Foegeding et al.162 However,
after storage for 2 weeks, 10% of the sausages
were Listeria-positive, a result contributing to the
current concern for the potential presence of this
foodborne pathogen in ready-to-eat foods, even if
the initial levels are much lower in most of the
cases. Later, Berry et al.163 showed that
coinoculation of P. acidilactici JD1-23 and
L. monocytogenes in frankfurters, followed by
vacuum packaging and storage at 4°C, prevented
the growth of the pathogen for at least 60 days.
Yousef et al.164 compared the ability of
pediocin PA-1 and a pediocin-producer to control
the growth of three L. monocytogenes strains in
wiener sausage exudates and showed that both
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approaches significantly decreased their growth
under refrigerated (4°C) and abusive (25°C) tem-
perature conditions. Although the decrease in List-
eria populations was faster when adding the bac-
teriocin, lower final levels were achieved using
the producing strain. Similar findings were ob-
tained by Degnan et al.165 Surface inoculation of
wiener sausages with L. monocytogenes and a
pediocin-producing Pediococcus strain, packag-
ing and storage at 4 and 25°C revealed that, in this
case, the producer was unable to grow or produce
the bacteriocin at 4°C, while reductions of up to
3.4 logs in Listeria levels were observed at 25°C.12
Motlagh et al.62 examined the effectiveness of
pediocin PA-1 in reducing the population of three
Listeria strains in sterile ground beef, sausage
mix, Cottage cheese, ice cream, and reconstituted
dry milk and observed that the bacteriocin action
was immediate and was not affected by the food
system tested. In addition, these authors showed
that the activity was concentration and strain de-
pendent. For example, 1350 AU ml–1 of pediocin
reduced the population of L. monocytogenes
ScottA, L. monocytogenes Ohio2, and L. ivanovii
ATCC 19119 in 1, 3, and 7 log cycles, respec-
tively. A listericidal effect (approximately 7 log
cycles) has been observed in slurries prepared
from vacuum-packaged ready-to-eat turkey breast
meat and challenged with L. monocytogenes in
the presence of diacetate and pediocin.166 The
increased antilisterial activity in slurries with
diacetate in combination with the bacteriocin were
due to synergistic effects. The listericidal activity
of pediocin PA-1 has also been evaluated in slur-
ries of beef muscle tissue, beef tallow, nonfat dry
milk, and butterfat inoculated with a mixture of
two L. monocytogenes strains.167 For all slurries
tested, the greatest decrease in Listeria counts
(1.2 to 1.8 log cycles) occurred within 1.5 min of
pediocin addition. In the same study, pediocin
was also encapsulated within phosphatidyl-cho-
line-based liposomes before addition to the slur-
ries or unencapsulated in slurries containing the
emulsifier Tween 80. In both cases, the pediocin
activity recovered from the slurries was notably
higher than that obtained after adding free pediocin
PA-1. Cold storage of L. monocytogenes-inocu-
lated pork in the presence of pediocin resulted in
a 2 log reduction after 24 h when compared with
untreated controls, regardless of whether the
samples were stored under air, vacuum, or a modi-
fied atmosphere.168
Goff et al.64 bound pediocin PA-1 to heat-
killed producer cells by adjusting the pH of the
medium to 6.0 and the preparation was added to
irradiation-sterilized raw chicken breast meat. The
results suggested that pediocin-treated raw chicken
exhibits antilisterial activity both before and after
cooking, and therefore may provide protection to
consumers against bacterial postprocessing
recontaminations and/or undercooking. Applica-
tion of pediocin to food packaging films may
constitute an alternative approach to control
L. monocytogenes in meats and poultry. Ming et
al.169 obtained a pediocin PA-1 extract from milk-
based media and prepared antilisterial cellulose
casings by internal coating with the pediocin
podwer (7.75 µg cm–2). The coated bags com-
pletely inhibited growth of inoculated
L. monocytogenes through 12 weeks storage at 4ºC.
B. Milk and Dairy Products
Inhibition of L. monocytogenes has been dem-
onstrated in several dairy systems, including
dressed Cottage cheese, half-and-half cream, and
cheese sauce.53 In all these food systems, there
was a rapid decrease in viable counts of
L. monocytogenes in the presence of pediocin
PA-1 podwer over the pH range 5.5 to 7.0 and at
both 4 and 32°C. Although a resurgence of the
pathogen after 7 days at 4°C in the midly acidic
and neutral dairy systems was described, decreases
in Listeria populations of at least 2 log cycles
were observed in such substrates. As cited above,
Motlagh et al.62 and Degnan et al.167 also reported
the antilisterial activity of pediocin PA-1 in dairy
products.
Despite the fact that pediococci are poorly
adapted to dairy substrates, it has been reported
that different pediocin-producing P. acidilactici
strains may contribute to L. monocytogenes con-
trol in milk when a very high inoculum (109 cfu
ml–1) is used.170 In contrast, the pediocin producer
Lb. plantarum WHE 92 was originally isolated
from a smear-surface soft cheese17 and, therefore,
it must be well-adapted to this dairy environment.
113
In fact, the presence of L. monocytogenes in
Munster cheese could be prevented by spraying a
cell suspension of Lb plantarum WHE 92 on the
cheese surface at the begining of the ripening
period.141 Although L. monocytogenes was some-
times detected at low levels (<50 cfu g–1) after
7 to 11 days of ripening, this microorganism was
unable to grow or survive in the presence of the
bacteriocin-producing strain in any of the samples
examined until the end of ripening (21 days). The
pathogen often reached counts higher than 104 cfu
ml–1 in control samples. Lb. plantarum WHE 92
did not interfere with the ripening process.
The L. lactis LL108 strain producing pediocin
PA-1122 lacks several properties required for appli-
cation in milk and dairy products.171 Therefore, in
order to fully exploit the commercial potential of a
pediocin-producing dairy starter culture, L. lactis
MM210, a strain that had been used previously in
Cheddar cheese manufacturing, was selected as an
alternative host for the ped operon-encoding plas-
mid.171 The antilisterial ability of the pediocin-
producing L. lactis starter culture was tested in
Cheddar cheeses coinoculated with the lactococcal
strain and a mixture of three L. monocytogenes
strains.171 In the experimental cheese, the counts of
the pathogen decreased by 1 log cycle within
1 week of ripening and then decreased by an addi-
tional log cycle within 3 months (final counts: 10
cfu g–1). In control cheeses made with an isogenic,
nonpediocin-producing L. lactis strain, Listeria
counts increased by approximately 4 log cycles
after 2 weeks of ripening and then gradually de-
creased to about 103 cfu g–1 after 6 months. The
presence of the plasmid encoding heterologous
pediocin production in the lactococcal starter cul-
ture did not affect its cheese-making quality.
C. Other Foodstuffs
With respect to other foodstuffs, the addition
of pediocin PA-1 to liquid whole egg containing
L. monocytogenes showed an immediate reduc-
tion in listerial counts and led to a greater reduc-
tion (of up to 1 log cycle) during heating when
compared with the levels found after heating un-
treated liquid whole egg.45 The addition of pediocin
PA-1 during fermentation of a vegetable (kimchi)
also notably decreased L. monocytogenes counts
and inhibited its growth during a minumum of 16
days.172
D. Legal Status
Up to date, nisin has been the only bacterio-
cin licenced as food preservative, although the
antimicrobial potential of pediocin PA-1 has al-
ready been commercially exploited as a pediocin
PA-1-containing fermentate. Owing to their typi-
cal association with food fermentation and their
long tradition as food-grade bacteria, pediocin
PA-1-producing LAB are “generally recognized
as safe” (GRAS), and therefore the benefits of
this bacteriocin can already be exploited using the
producer strains or their fermentates, a practice
for which special labeling would not be required.173
In fact, a wide use of bacteriocin-producing LAB
in food fermentations has inadvertently or empiri-
cally been made for centuries, and it seems clear
that bacteriocin residues are present in our daily
food supply.7 Currently, there are some European
and US patents covering the use of pediocin PA-1
in dairy174 and meat products.175,176
VIII. CONCLUSION AND FUTURE
PROSPECTS
Many LAB bacteriocins have been identified
over the years1 but only nisin, and pediocin PA-1
have been examined extensively in application
studies in food systems. Although pediocin PA-1
has an antimicrobial spectrum not as wide as that
of nisin, it is generally more active against List-
eria monocytogenes. The fact that this microor-
ganism is of special concern to the food industry,
because of the high mortality and morbidity rates
associated with listeriosis,45 may help to increase
the use of pediocin PA-1 as a food biopreservative.
Pediocin PA-1 has been the subject of consid-
erable interest in recent years. However, there are
still many aspects that need further research. Its
three-dimensional structure and mode of action
are far from completely elucidated. The establish-
ment of the relationships between its structure
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and its biological activity will be of particular
interest because this knowledge may facilitate the
enhancement of pediocin PA-1 activity and a
greater understanding of the mechanisms of bac-
terial resistance to the peptide. Protein engineer-
ing, genetic engineering, and/or chemical synthe-
sis may lead to the development of new
antimicrobial peptides with improved properties,
based on some features of the pediocin PA-1
molecule (pediocin PA-1 variants, hybrid bacte-
riocins). The use of genetically modified organ-
isms for the in situ production of pediocin PA-1
may meet with opposition from industries and/or
consumers. Therefore, the development of (in-
ducible) “food-grade” genetic systems for pediocin
PA-1 production would be highly relevant. En-
hancement of the pediocin PA-1 productivity when
it is heterologously (co)produced by starter cul-
tures may contribute to widen the applicability of
pediocin PA-1 in foodstuffs.
The approval of pediocin PA-1 as a food
additive would require the existence of methods
that allow the specific detection of this bacterio-
cin in foods. The recent development of specific
polyclonal antibodies is a promising step in this
direction. Specific antibodies could also facilitate
the (industrial scale) purification of pediocin PA-1
through the use of immunoaffinity columns.
Inasmuch as different laboratories worldwide
are working on the elucidation of all these points,
we are confident that pediocin PA-1 or pediocin
PA-1-like peptides will be included in the next
generation of food preservatives.
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